Natco Pharma has reported results for second quarter ended September 30, 2019.
The company has reported 36.72% fall in its net profit at Rs 122.20 crore for the quarter under review as compared to Rs 193.10 crore for the same quarter in the previous year. Total income of the company decreased by 12.54% at Rs 491.60 crore for Q2FY20 as compared Rs 562.10 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 35.19% in its net profit at Rs 117.70 crore for the quarter under review as compared to Rs 181.60 crore for the same quarter in the previous year. Total income of the company decreased by 11.07% at Rs 518.90 crore for Q2FY20 as compared Rs 583.50 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1464.85 |
Dr. Reddys Lab | 5955.65 |
Cipla | 1477.15 |
Zydus Lifesciences | 1050.35 |
Lupin | 1603.55 |
View more.. |